S

SSY Group Ltd
HKEX:2005

Watchlist Manager
SSY Group Ltd
HKEX:2005
Watchlist
Price: 3.73 HKD -2.1% Market Closed
Market Cap: 11B HKD
Have any thoughts about
SSY Group Ltd?
Write Note

SSY Group Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SSY Group Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
SSY Group Ltd
HKEX:2005
Total Current Assets
HK$5.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Current Assets
HK$8.2B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
16%
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Current Assets
ÂĄ15.1B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
11%
Sino Biopharmaceutical Ltd
HKEX:1177
Total Current Assets
ÂĄ25.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
14%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Current Assets
HK$197.6B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Current Assets
$1B
CAGR 3-Years
-1%
CAGR 5-Years
28%
CAGR 10-Years
27%
No Stocks Found

SSY Group Ltd
Glance View

Market Cap
11.1B HKD
Industry
Pharmaceuticals

SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 4,800 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Intrinsic Value
5.41 HKD
Undervaluation 31%
Intrinsic Value
Price
S

See Also

What is SSY Group Ltd's Total Current Assets?
Total Current Assets
5.3B HKD

Based on the financial report for Jun 30, 2024, SSY Group Ltd's Total Current Assets amounts to 5.3B HKD.

What is SSY Group Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
10%

Over the last year, the Total Current Assets growth was 4%. The average annual Total Current Assets growth rates for SSY Group Ltd have been 6% over the past three years , 11% over the past five years , and 10% over the past ten years .

Back to Top